Versor Investments LP Pulmonx Corp Transaction History

Versor Investments LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.71 - $14.65 $165,995 - $279,199	19,058 New	19,058 $176,000
Q3 2023 Nov 06, 2023	SELL	$9.88 - $14.0 $46,436 - $65,800	-4,700 Reduced 20.59%	18,123 $187,000
Q2 2023 Aug 07, 2023	BUY	$10.78 - $13.65 $132,841 - $168,208	12,323 Added 117.36%	22,823 $299,000
Q1 2023 May 05, 2023	SELL	$7.49 - $12.54 $37,450 - $62,699	-5,000 Reduced 32.26%	10,500 $117,000
Q4 2022 Jan 30, 2023	BUY	$4.92 - $17.35 $76,260 - $268,925	15,500 New	15,500 $130,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.